Stay updated on UNCOVER-2: Guselkumab Clinical Trial

Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.5.3 to v3.5.4. This change represents a minor maintenance update to the page's versioning.
    Difference
    0.0%
    Check dated 2026-05-17T10:25:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov site version label at the bottom of the page (from v3.5.2 to v3.5.3), without changing the trial’s displayed content.
    Difference
    0.0%
    Check dated 2026-04-25T17:56:48.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. The page content and user-facing features remain unchanged.
    Difference
    0.0%
    Check dated 2026-04-18T13:17:02.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T17:25:17.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T11:40:58.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior funding-status notice (Revision: v3.4.1). These are routine site maintenance updates that do not alter the study details on the page.
    Difference
    0.2%
    Check dated 2026-02-12T14:47:23.000Z thumbnail image

Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.